Synageva BioPharma Falls 3%
Shares of Synageva BioPharma (NASDAQ: GEVA) have lost 3.34% on Monday after a strong showing last week. Volume has been slightly above normal with around 81,000 GEVA shares trading hands compared to a 3-month daily average of 73,000.
The stock has risen around 157% over the last 6 months. Over the last 3 months, GEVA has added a little more than 6%. At current prices, the company has a market cap of $844 million.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.